How is Acute Respiratory Distress Syndrome (ARDS) Diagnosed?

Acute Respiratory Distress Syndrome (ARDS) is generally assessed by an intensivist, pulmonologist or critical-care specialist using clinical findings, oxygenation measurements and chest imaging. Diagnostic evaluation may include pulse oximetry, arterial blood gas analysis, chest X-ray and, when required, a CT scan of the chest. Blood tests and other investigations may also be performed to identify the underlying cause and assess organ function.

How is Acute Respiratory Distress Syndrome (ARDS) Treated Based on Severity?

The treatment of Acute Respiratory Distress Syndrome is adjusted according to the severity of respiratory failure, oxygenation, underlying cause and response to respiratory support. The table below summarises the main treatment approaches for ARDS according to severity:

Severity Main Treatment Approach
Mild ARDS Supplemental oxygen or other appropriate respiratory support, treatment of the underlying cause, lung-protective principles where mechanical ventilation is required and careful fluid management
Moderate ARDS Lung-protective mechanical ventilation when required, appropriate PEEP, treatment of the underlying cause and consideration of prone positioning or neuromuscular blockade according to the clinical situation
Severe ARDS Lung-protective mechanical ventilation, prone positioning for more than 12 hours per day when indicated, appropriate PEEP, conservative fluid management and selected adjunctive treatments
Severe ARDS Not Responding to Conventional Treatment Further optimisation of respiratory support and consideration of venovenous ECMO in selected patients

Stages of Acute Respiratory Distress Syndrome (ARDS) and Their Treatment

Healthcare providers may describe Acute Respiratory Distress Syndrome (ARDS) in three stages: exudative, proliferative and fibrotic. These stages describe the progression of lung inflammation, fluid accumulation and the healing process. Not every person with ARDS progresses to the fibrotic stage. Treatment remains focused on supporting breathing, protecting the lungs and managing the underlying cause throughout these stages.

The table below explains the three stages of Acute Respiratory Distress Syndrome ARDS) and the treatment approach generally associated with each stage:

Stage Treatment Approach
Exudative Stage Oxygen therapy, treatment of the underlying cause, careful fluid management and appropriate respiratory support, including mechanical ventilation when required.
Proliferative Stage Continued lung-protective ventilation when required, appropriate oxygen support, treatment of the underlying cause and monitoring for complications.
Fibrotic Stage Continued respiratory support and management of complications, with treatment tailored to the patient's lung function and clinical response.

Other Treatments for Acute Respiratory Distress Syndrome (ARDS)

Acute Respiratory Distress Syndrome (ARDS) treatment may involve several forms of respiratory support and supportive care. The treatment selected depends on the severity of respiratory failure and the patient's clinical response. Other common ARDS treatments recommended by doctors are as follows:

  1. Oxygen Therapy Supplemental oxygen is used to improve blood oxygen levels and may be delivered through a nasal cannula, face mask or other oxygen-delivery system according to the patient's needs.

  2. High-Flow Nasal Oxygen High-flow nasal oxygen provides warmed and humidified oxygen at a high flow rate. This may be used in selected patients who can continue breathing independently.

  3. Non-Invasive Ventilation Non-invasive ventilation, such as continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP), may be considered in selected patients who can protect their airway and do not require immediate invasive ventilation.

  4. Mechanical Ventilation Mechanical ventilation supports breathing when oxygen therapy or non-invasive respiratory support is insufficient. Alongside it, lung-protective ventilation is used to reduce further ventilator-related lung injury.

  5. Lung-Protective Ventilation Lung-protective ventilation uses lower tidal volumes and limits airway pressures to reduce additional damage to already injured lungs.

  6. Prone Positioning Prone positioning involves placing a patient on their stomach to improve oxygenation and is strongly recommended for more than 12 hours per day in selected adults with severe ARDS.

  7. Positive End-Expiratory Pressure Positive end-expiratory pressure (PEEP) helps keep airways and alveoli open at the end of exhalation and may be adjusted according to the severity of ARDS and the patient's response.

  8. Conservative Fluid Management Careful management of intravenous fluids can help limit excess fluid accumulation while maintaining adequate circulation and organ function.

  9. Neuromuscular Blocking Medicines Neuromuscular blocking medicines may be considered for selected patients with early severe ARDS, particularly when they are required to facilitate mechanical ventilation.

  10. Corticosteroids Systemic corticosteroids may be used in selected patients with ARDS, with the choice and duration determined by the treating medical team. The American Thoracic Society suggests corticosteroids for patients with ARDS as a conditional recommendation.

  11. Extracorporeal Membrane Oxygenation (ECMO) Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be considered for selected patients with severe ARDS who continue to have severe respiratory failure despite appropriate conventional treatment.

Oral Medications for Acute Respiratory Distress Syndrome (ARDS)

There is no single oral medicine that directly cures Acute Respiratory Distress Syndrome (ARDS). Medicines are selected according to the underlying cause and complications. Common oral medications prescribed by doctors for ARDS are as follows:

  • Antibiotics may be used when ARDS is associated with a bacterial infection.

  • Antiviral medicines may be used for certain viral infections when clinically indicated.

  • Corticosteroids may be prescribed for selected patients with ARDS.

  • Anticoagulants may be used when required to prevent or treat blood clots.

  • Other medicines may be prescribed to manage the underlying illness or complications.

Many patients with moderate or severe ARDS receive medicines through intravenous or other hospital-based routes rather than through oral medicines.

Ayurvedic and Alternative Treatments for Acute Respiratory Distress Syndrome (ARDS)

Ayurvedic and alternative treatments are not proven to cure Acute Respiratory Distress Syndrome (ARDS). Breathing exercises in consultation with a healthcare professional may be used. On the other hand, meditation may be used for stress management.

Do not use any herbal products without consulting a doctor, as they may interfere with medications.

Home Care for Acute Respiratory Distress Syndrome (ARDS)

Active moderate or severe Acute Respiratory Distress Syndrome (ARDS) requires hospital-based treatment and monitoring and may require intensive care. Home care can support recovery after discharge. Common home care practices recommended by doctors for ARDS are as follows:

  • Take prescribed medicines as directed.

  • Attend all scheduled follow-up appointments.

  • Follow the pulmonary rehabilitation programme recommended by the healthcare team.

  • Perform breathing and physical exercises as advised.

  • Maintain adequate nutrition.

  • Avoid smoking and second-hand smoke.

  • Follow recommended measures to reduce the risk of respiratory infections.

  • Seek medical attention if breathlessness suddenly worsens or new respiratory symptoms develop.

Latest Treatment for Acute Respiratory Distress Syndrome (ARDS)

Recent guidelines have updated the approach to treating Acute Respiratory Distress Syndrome (ARDS), with greater emphasis on individualised, lung-protective respiratory support. The 2024 American Thoracic Society (ATS) clinical practice guideline suggests the use of corticosteroids in patients with ARDS, venovenous extracorporeal membrane oxygenation (VV-ECMO) in selected patients with severe ARDS, and neuromuscular blocking medicines in selected patients with early severe ARDS. It also provides updated recommendations on positive end-expiratory pressure (PEEP).

The ATS and European Society of Intensive Care Medicine (ESICM) guidance supports lung-protective ventilation and prolonged prone positioning in appropriate patients, while ECMO may be considered when severe respiratory failure persists despite conventional treatment.

How Long Does Acute Respiratory Distress Syndrome (ARDS) Treatment Take?

The duration of Acute Respiratory Distress Syndrome (ARDS) treatment varies according to the severity of respiratory failure, the underlying cause and the response to treatment. The table below provides approximate treatment durations for major ARDS treatment approaches:

Treatment Approximate Duration
Oxygen therapy Several days to weeks, depending on recovery
Non-invasive respiratory support Several days or longer, depending on clinical response
Mechanical ventilation Several days to weeks in patients with severe Acute Respiratory Distress Syndrome (ARDS)
Prone positioning Repeated sessions, with severe cases generally receiving prolonged daily sessions when indicated
Neuromuscular blocking medicines Short-term use in selected patients
Antibiotic treatment Depends on the underlying infection and clinical response
ECMO Usually several days to weeks in selected patients
Pulmonary rehabilitation Several weeks to months after hospital discharge

The overall hospital stay may be longer than the duration of an individual treatment because patients may require continued monitoring and rehabilitation after their breathing has improved.

Acute Respiratory Distress Syndrome (ARDS) Treatment Side Effects

Common side effects of ARDS treatment are as follows:

  • Ventilator-associated lung injury

  • Ventilator-associated pneumonia

  • Low blood pressure

  • Muscle weakness

  • Pressure injuries associated with prolonged positioning

  • Blood clots

  • Hospital-acquired infections

  • Medication-related complications

  • Delirium during intensive care

  • Physical weakness after prolonged hospitalisation

The risk of these complications varies according to the treatment required, duration of intensive care and the patient's overall condition.

Lifestyle Changes for Acute Respiratory Distress Syndrome (ARDS)

Lifestyle measures are mainly relevant during recovery from Acute Respiratory Distress Syndrome (ARDS) and can support rehabilitation and general respiratory health. Common lifestyle changes recommended by doctors for ARDS are as follows:

  • Stop smoking.

  • Avoid second-hand smoke.

  • Follow a gradual exercise programme.

  • Attend pulmonary rehabilitation if recommended.

  • Maintain adequate nutrition.

  • Maintain a healthy weight where appropriate.

  • Get sufficient sleep.

  • Follow recommended vaccination schedules.

  • Reduce unnecessary exposure to respiratory infections.

  • Attend follow-up appointments and complete recommended rehabilitation.

Triggers That Can Worsen Acute Respiratory Distress Syndrome (ARDS) Symptoms

Acute Respiratory Distress Syndrome (ARDS) is usually associated with another serious illness or injury. Hence, the factors that worsen the patient's condition depend on the underlying cause. Common triggers of ARDS are:

  • Ongoing or worsening infection

  • Aspiration of food, liquid or stomach contents

  • Exposure to smoke or harmful respiratory irritants

  • Continued inflammation associated with the underlying illness

  • Delayed treatment of a serious underlying infection or condition

  • New respiratory infections during recovery

Treatment Cost for Acute Respiratory Distress Syndrome (ARDS)

The cost of treating Acute Respiratory Distress Syndrome (ARDS) in India varies, depending on things like the cause of the illness, how long someone stays in the ICU, the type of breathing support they need, and any complications. ICU care usually costs between ₹10,000 and ₹30,000 per day or sometimes more.

Extra treatments like mechanical ventilation, tests, medicines, and specialist care can add to the total cost. In severe cases, if a patient needs a longer ICU stay or ECMO, the expenses can go up to several lakh rupees in such cases.

Does Health Insurance Cover Acute Respiratory Distress Syndrome (ARDS) Treatment in India?

Yes. Health insurance covers medically necessary hospitalisation and ICU care for Acute Respiratory Distress Syndrome (ARDS), subject to the terms of the policy. Coverage may include ICU treatment, diagnostic tests, oxygen therapy, mechanical ventilation, medicines and other covered hospital services. The exact coverage may vary from one plan to another.

Waiting periods will also apply before a claim can be raised. In case of pre-existing ARDS, a waiting period of up to 3 years may apply.

People should check their policy documents to know the sum insured, coverage, room-rent limits, co-payment, waiting periods, exclusions and other policy conditions.

Frequently Asked Questions

  • Q1. Can Acute Respiratory Distress Syndrome (ARDS) be cured?

    Ans: Acute Respiratory Distress Syndrome (ARDS) can improve when the underlying cause is treated and appropriate respiratory support is provided. The recovery period and outcome depend on the severity of ARDS, the underlying condition and the patient's response to treatment.
  • Q2. What is the main treatment for Acute Respiratory Distress Syndrome (ARDS)?

    Ans: The main treatment for Acute Respiratory Distress Syndrome (ARDS) involves supportive respiratory care, treatment of the underlying cause, lung-protective ventilation when required and careful fluid management.
  • Q3. Does Acute Respiratory Distress Syndrome (ARDS) always require a ventilator?

    Ans: Acute Respiratory Distress Syndrome (ARDS) does not always require invasive mechanical ventilation. Some patients may initially receive supplemental oxygen or other non-invasive respiratory support, while severe ARDS may require mechanical ventilation.
  • Q4. How long does Acute Respiratory Distress Syndrome (ARDS) treatment take?

    Ans: Acute Respiratory Distress Syndrome (ARDS) treatment may continue for several days or weeks, depending on the severity of respiratory failure, underlying cause and response to treatment. Recovery and rehabilitation may continue for several weeks or months after discharge.
  • Q5. Is prone positioning used for Acute Respiratory Distress Syndrome (ARDS)?

    Ans: Prone positioning is used as part of Acute Respiratory Distress Syndrome (ARDS) treatment in selected patients, particularly adults with severe ARDS. Current American Thoracic Society guidance recommends prone positioning for more than 12 hours per day in severe ARDS.
  • Q6. When is mechanical ventilation used for Acute Respiratory Distress Syndrome (ARDS)?

    Ans: Mechanical ventilation is used for Acute Respiratory Distress Syndrome (ARDS) when oxygen therapy or non-invasive respiratory support cannot provide adequate respiratory support. Lung-protective ventilation is used to reduce additional lung injury.
  • Q7. Is oxygen therapy used for Acute Respiratory Distress Syndrome (ARDS)?

    Ans: Oxygen therapy is commonly used for Acute Respiratory Distress Syndrome (ARDS) to improve blood oxygen levels.
  • Q8. What medicines are used to treat Acute Respiratory Distress Syndrome (ARDS)?

    Ans: Medicines used during Acute Respiratory Distress Syndrome (ARDS) treatment depend on the underlying cause and complications. They may include antibiotics for bacterial infections, antiviral medicines for selected viral infections and corticosteroids in appropriate patients.
  • References

    • https://www.mayoclinic.org/diseases-conditions/ards/diagnosis-treatment/drc-20355581

    • https://my.clevelandclinic.org/health/diseases/15283-acute-respiratory-distress-syndrome-ards

    • https://www.healthline.com/health/acute-respiratory-distress-syndrome

    • https://www.nhs.uk/conditions/acute-respiratory-distress-syndrome/

    • https://pubmed.ncbi.nlm.nih.gov/38032683/

    • https://www.nhlbi.nih.gov/health/ards/treatment

    • https://pubmed.ncbi.nlm.nih.gov/37326646/

Other Disease Treatment Pages